| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | Rainer Rupprecht | |
| P2860 | cites work | Allopregnanolone as a mediator of affective switching in reproductive mood disorders | Q26866177 |
| Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects | Q28249253 | ||
| Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake | Q28293369 | ||
| Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain | Q28296651 | ||
| Allopregnanolone and mood disorders | Q28297377 | ||
| Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis | Q28301125 | ||
| Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives | Q33707601 | ||
| Neurosteroids act on recombinant human GABAA receptors | Q34187011 | ||
| Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. | Q34283368 | ||
| Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans | Q34305538 | ||
| Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor | Q36174752 | ||
| Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis | Q37493818 | ||
| Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders | Q37814088 | ||
| The role of allopregnanolone in depression and anxiety | Q38161615 | ||
| Recent advances in the pharmacotherapy of infantile spasms | Q38185985 | ||
| The translocator protein as a drug target in Alzheimer's disease. | Q38195637 | ||
| Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results | Q44309870 | ||
| P921 | main subject | research question | Q1438033 |
| P304 | page(s) | 268 | |
| P577 | publication date | 2014-09-19 | |
| P1433 | published in | Frontiers in Cellular Neuroscience | Q2131509 |
| P1476 | title | New perspectives in neurosteroid action: open questions for future research | |
| P478 | volume | 8 |
| Q39434865 | Editorial on "New perspectives in neurosteroids action: a special player allopregnanolone". |
| Q47369108 | Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism. |
| Q64236596 | Neuroactive Steroids Reverse Tonic Inhibitory Deficits in Fragile X Syndrome Mouse Model |
| Q90124577 | Stress and drug abuse-related disorders: The promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway |
Search more.